ONCOLOGY INSTITUTE INC/THE

Oncology Institute insiders trade sharply—C.M.O. Podnos Yale buys low, sells high to manage liquidity, not confidence. Learn the implications for investors.

Oncology Institute insider buying spikes: director Chernett Jorey’s latest 15,000‑share purchase signals confidence in value‑based care growth and a potential undervalued upside for long‑term investors.

Insider buying at Oncology Institute Inc. shows new bullish confidence—17,185 shares, no cash, and a strong balance sheet—hinting at future upside in oncology services.

Insider buying of Oncology Institute stock rises as Jorey’s incremental purchases signal confidence amid a 14.6% monthly gain and 134.8% YTD surge.

Insider sales and buys at Oncology Institute reveal mixed sentiment—does the recent sell signal confidence drops or just a planned exit? Discover the implications.

Insider buy of 12k shares at $4.75 shows The Oncology Institute’s strong growth momentum and investor confidence in its value‑based oncology services.